GO:1900225 regulation of NLRP3 inflammasome complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900225 describes any process that modulates the frequency, rate or extent of NLRP3 inflammasome complex assembly, a central step in innate immune activation.
• NLRP3 inflammasome assembly requires a two-step mechanism: priming (transcriptional and post-translational upregulation of NLRP3 and pro-IL-1beta) and activation (oligomerization and speck formation) [1,4].
• Multiple regulators control this process, including autophagy/mitophagy, ZBP1, TAK1, hexokinase dissociation from mitochondria, and ER-mitochondria contact sites [2,3,5,6,8].
• Dysregulation of NLRP3 inflammasome assembly is linked to inflammatory diseases, neurodegeneration, metabolic disorders, and cancer [1,7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect causal roles of regulators in this pathway [1,2].
• EDITGENE provides comprehensive CRISPR services to study GO:1900225, including library screening and bioinformatics for target discovery.
Description
The NLRP3 inflammasome is a multiprotein complex that assembles in response to diverse danger signals and mediates caspase-1 activation, leading to the maturation of pro-inflammatory cytokines IL-1beta and IL-18 and to pyroptotic cell death [1,4]. The process of NLRP3 inflammasome complex assembly is tightly regulated to prevent aberrant inflammation, and the Gene Ontology term GO:1900225 (regulation of NLRP3 inflammasome complex assembly) captures any process that modulates the frequency, rate or extent of this assembly. Understanding the regulatory mechanisms of NLRP3 inflammasome assembly is critical because its dysregulation contributes to a wide range of human diseases, including autoinflammatory disorders, neurodegeneration, metabolic syndrome, and cancer [1,7]. Recent studies have identified numerous regulators, such as autophagy and mitophagy pathways, ZBP1, TAK1, and metabolic factors like hexokinase dissociation from mitochondria, which control NLRP3 inflammasome assembly at multiple levels [2,3,5,6]. This article provides a research-grade overview of GO:1900225, integrating authoritative QuickGO definitions with real PubMed literature to guide experimental design and therapeutic targeting.
regulation of NLRP3 inflammasome complex assembly At A Glance
| GO ID | GO:1900225 |
|---|---|
| GO term | regulation of NLRP3 inflammasome complex assembly |
| Ontology | biological_process |
| Synonym | regulation of NALP3 inflammasome complex assembly; regulation of NLRP3 inflammasome activation |
| Major function | Modulates the frequency, rate or extent of NLRP3 inflammasome complex assembly, a key innate immune response |
| Related processes | Inflammasome activation, pyroptosis, cytokine maturation, autophagy, mitophagy [2,3] |
| Key regulators | NLRP3, ASC, caspase-1, ZBP1, TAK1, hexokinase, autophagy machinery [1,2,5,6] |
| Disease relevance | Inflammatory diseases, neurodegeneration, metabolic disorders, cancer [1,7] |
What Is GO:1900225?
GO:1900225, regulation of NLRP3 inflammasome complex assembly, is a biological process defined as any process that modulates the frequency, rate or extent of NLRP3 inflammasome complex assembly. This includes both positive and negative regulation of the assembly of the NLRP3 inflammasome, a cytosolic multiprotein complex that forms in response to pathogens and danger signals. The term encompasses molecular events such as priming, oligomerization, and speck formation, as well as cellular processes that control these steps, including autophagy, mitochondrial dynamics, and signaling cascades [1,2,4].
Why Is regulation of NLRP3 inflammasome complex assembly Important in Cell Biology?
Regulation of NLRP3 inflammasome complex assembly is a central checkpoint in innate immunity and inflammation. Precise control of this process is essential to mount effective host defense against pathogens while avoiding excessive inflammation that can damage tissues. Dysregulation of NLRP3 inflammasome assembly is implicated in the pathogenesis of numerous human diseases, including cryopyrin-associated periodic syndromes, Alzheimer's disease, type 2 diabetes, atherosclerosis, and cancer [1,7]. Therefore, understanding the molecular mechanisms that regulate NLRP3 inflammasome assembly provides opportunities for therapeutic intervention and biomarker development.
• Controls innate immune responses to infection and danger signals.
• Regulates maturation and secretion of pro-inflammatory cytokines IL-1beta and IL-18.
• Determines the balance between protective immunity and pathological inflammation.
• Dysregulation is linked to autoinflammatory diseases such as cryopyrin-associated periodic syndromes.
• Implicated in neurodegenerative diseases including Alzheimer's and Parkinson's.
• Plays a role in metabolic disorders such as type 2 diabetes and obesity.
• Contributes to tumorigenesis and tumor immunity.
• Autophagy and mitophagy are key negative regulators of NLRP3 inflammasome assembly.
• ZBP1 and TAK1 are master regulators of NLRP3 inflammasome and PANoptosis [3,5].
• Hexokinase dissociation from mitochondria promotes NLRP3 inflammasome assembly.
What Happens During regulation of NLRP3 inflammasome complex assembly?
Priming (Signal 1)
In simple terms: The first step that prepares the cell by increasing the amount of NLRP3 protein and its substrate.
Priming involves transcriptional upregulation of NLRP3 and pro-IL-1beta via NF-kB activation, as well as post-translational modifications of NLRP3 that keep it in an inactive but ready state [1,4]. This step is essential for subsequent inflammasome assembly and is regulated by various signaling pathways, including those involving TAK1.
Activation and Oligomerization (Signal 2)
In simple terms: The second step where NLRP3 molecules come together to form a large complex.
Upon activation by diverse stimuli such as ATP, nigericin, or crystalline substances, NLRP3 undergoes conformational changes that lead to its oligomerization and recruitment of the adaptor protein ASC, which in turn recruits pro-caspase-1 [1,4]. This assembly forms a speck-like structure that serves as a platform for caspase-1 activation. Recent studies show that hexokinase dissociation from mitochondria promotes VDAC oligomerization, facilitating NLRP3 inflammasome assembly.
Regulation by Autophagy and Mitophagy
In simple terms: Cellular recycling processes that break down inflammasome components to limit inflammation.
Autophagy and mitophagy negatively regulate NLRP3 inflammasome assembly by targeting NLRP3, ASC, or damaged mitochondria for degradation. This regulatory mechanism prevents excessive inflammasome activation and is critical for maintaining cellular homeostasis. Defects in autophagy lead to enhanced NLRP3 inflammasome assembly and increased IL-1beta secretion.
Regulation by ZBP1 and TAK1
In simple terms: Specific proteins that act as master switches to control inflammasome assembly and cell death.
ZBP1 and TAK1 are key regulators of NLRP3 inflammasome assembly and PANoptosis [3,5]. ZBP1 senses nucleic acids and triggers inflammasome activation, while TAK1 restricts inflammasome assembly to prevent uncontrolled inflammation. Their interplay determines cell fate decisions between pyroptosis, apoptosis, and necroptosis [3,5].
ER-Mitochondria Contacts
In simple terms: Physical connections between two cellular organelles that influence inflammasome assembly.
Augmented endoplasmic reticulum-mitochondria contacts mediate stress-induced NLRP3 inflammasome assembly in microglia, contributing to depression-like behavior in mice. This highlights the role of organelle communication in regulating inflammasome assembly.
Key Genes Involved in GO:1900225 regulation of NLRP3 inflammasome complex assembly
The following genes and proteins are central to the regulation of NLRP3 inflammasome complex assembly, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Core component of the inflammasome; senses danger signals and oligomerizes | Primary target for studying inflammasome assembly |
| ASC (PYCARD) | Adaptor protein that bridges NLRP3 and caspase-1 | Essential for speck formation and caspase-1 activation |
| CASP1 | Cysteine protease that matures IL-1beta and IL-18 | Effector of inflammasome function |
| ZBP1 | Nucleic acid sensor that regulates NLRP3 inflammasome and PANoptosis | Master regulator of cell death and inflammation [3,5] |
| TAK1 (MAP3K7) | Kinase that restricts NLRP3 inflammasome assembly | Negative regulator preventing excessive inflammation |
| HK1/HK2 | Hexokinases that dissociate from mitochondria to promote VDAC oligomerization | Metabolic regulator of inflammasome assembly |
| VDAC1/2/3 | Mitochondrial porins that oligomerize to facilitate NLRP3 assembly | Link between metabolism and inflammasome |
| ATG5 | Autophagy-related protein essential for autophagosome formation | Mediates negative regulation of inflammasome |
| ATG7 | Autophagy-related protein involved in LC3 lipidation | Required for mitophagy-mediated inflammasome control |
| SQSTM1 (p62) | Autophagy receptor that targets ubiquitinated inflammasome components | Selective autophagy of NLRP3 |
| OPTN | Autophagy receptor involved in mitophagy | Regulates mitochondrial homeostasis and inflammasome |
| NFKB1 | Transcription factor for priming of NLRP3 and pro-IL-1beta | Controls signal 1 of inflammasome activation |
| IL1B | Pro-inflammatory cytokine matured by caspase-1 | Readout of inflammasome activity |
| IL18 | Pro-inflammatory cytokine matured by caspase-1 | Readout of inflammasome activity |
| GSDMD | Gasdermin D executes pyroptosis downstream of inflammasome | Links inflammasome to cell death |
| P2RX7 | ATP-gated ion channel that activates NLRP3 inflammasome | Common activator in experimental models |
| NEK7 | Kinase required for NLRP3 inflammasome assembly | Facilitates NLRP3 oligomerization |
How Is regulation of NLRP3 inflammasome complex assembly Regulated?
Regulation of NLRP3 inflammasome complex assembly is controlled at multiple levels. Priming is regulated by NF-kB signaling, which induces NLRP3 and pro-IL-1beta expression. Post-translational modifications such as phosphorylation, ubiquitination, and SUMOylation modulate NLRP3 activity [1,7]. Autophagy and mitophagy act as negative regulators by degrading inflammasome components or damaged mitochondria. ZBP1 and TAK1 are master regulators that integrate stress signals to control inflammasome assembly and cell death [3,5]. Metabolic factors such as hexokinase dissociation from mitochondria and ER-mitochondria contact sites also influence assembly [6,8]. These regulatory mechanisms ensure that inflammasome activation is tightly controlled in space and time.
regulation of NLRP3 inflammasome complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Cryopyrin-associated periodic syndromes (CAPS) | Knock-in mice with gain-of-function NLRP3 mutations |
| NLRP3 | Alzheimer's disease | APP/PS1 mice with NLRP3 knockout |
| IL1B | Autoinflammatory fever syndromes | IL-1beta reporter mice |
| ZBP1 | PANoptosis in infection and inflammation | Zbp1 knockout mice [3,5] |
| HK2 | Metabolic inflammation | Hexokinase dissociation mutants |
Inflammatory and Autoimmune Diseases
Dysregulated NLRP3 inflammasome assembly is a hallmark of cryopyrin-associated periodic syndromes (CAPS), which are caused by gain-of-function mutations in NLRP3. Excessive IL-1beta production drives systemic inflammation, and therapeutic blockade of IL-1 is effective. Other inflammatory diseases such as gout, atherosclerosis, and inflammatory bowel disease also involve aberrant NLRP3 inflammasome activation [1,7].
Neurodegeneration
In Alzheimer's disease and Parkinson's disease, NLRP3 inflammasome assembly in microglia contributes to neuroinflammation and neuronal damage. Amyloid-beta and alpha-synuclein can activate the NLRP3 inflammasome, and genetic or pharmacological inhibition of NLRP3 reduces pathology in mouse models. ER-mitochondria contacts in microglia mediate depression-like behavior via NLRP3 inflammasome assembly.
Metabolic Disorders
Obesity and type 2 diabetes are associated with chronic low-grade inflammation driven in part by NLRP3 inflammasome activation in adipose tissue and pancreatic islets. Saturated fatty acids and ceramides can trigger NLRP3 inflammasome assembly, contributing to insulin resistance.
Cancer
NLRP3 inflammasome assembly has dual roles in cancer. In some contexts, it promotes anti-tumor immunity by enhancing IL-18 and IFN-gamma production, while in others it fosters a pro-tumorigenic inflammatory microenvironment. Understanding the regulation of NLRP3 inflammasome assembly is therefore important for cancer immunotherapy.
From regulation of NLRP3 inflammasome complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate NLRP3 inflammasome assembly? | CRISPR knockout in THP-1 or bone marrow-derived macrophages |
| Does a specific point mutation in NLRP3 affect assembly? | Point mutation knock-in via CRISPR in cell lines |
| Does tagging NLRP3 with a fluorescent protein affect its function? | Knock-in of GFP/mCherry tag at endogenous locus |
| Does overexpression of a regulator enhance inflammasome assembly? | Lentiviral overexpression in macrophages |
| Which genes are essential for inflammasome assembly? | Genome-wide CRISPR library screening |
| How does autophagy regulate inflammasome assembly? | ATG5 or ATG7 knockout cells |
How to Study the regulation of NLRP3 inflammasome complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for inflammasome assembly | Discovery of novel regulators |
| Immunoprecipitation + mass spectrometry | Protein interactions and complex composition | Mapping inflammasome interactome |
| ASC speck imaging | Inflammasome assembly and aggregation | Visualizing activation in live cells |
| IL-1beta ELISA | Cytokine secretion | Functional readout of inflammasome activation |
| Western blot for caspase-1 | Caspase-1 cleavage and activation | Confirming inflammasome function |
| RNA-seq | Transcriptional changes during priming | Identifying NF-kB target genes |
| Mitophagy flux assays | Autophagic degradation of mitochondria | Assessing negative regulation |
| Proximity ligation assay | In situ protein-protein interactions | Detecting NLRP3-ASC association |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify novel regulators of NLRP3 inflammasome assembly. Cells are transduced with a lentiviral sgRNA library, selected, and then stimulated with NLRP3 activators. Enrichment or depletion of sgRNAs in activated versus control cells reveals candidate genes.
Proteomics and Interactomics
Mass spectrometry-based proteomics can map the composition of the NLRP3 inflammasome complex and identify post-translational modifications. Proximity labeling or immunoprecipitation followed by mass spectrometry can reveal dynamic interactions during assembly [1,4].
Imaging of Inflammasome Specks
Fluorescence microscopy and live-cell imaging can visualize ASC speck formation, a hallmark of NLRP3 inflammasome assembly. Tagged ASC or NLRP3 with fluorescent proteins allows real-time monitoring of assembly in response to stimuli [1,6].
Cytokine Secretion Assays
ELISA for IL-1beta and IL-18 in culture supernatants is a standard readout of inflammasome activation. This method is often combined with Western blotting for caspase-1 cleavage to confirm assembly and function.
How CRISPR Can Be Used to Study GO:1900225 regulation of NLRP3 inflammasome complex assembly
Knockout
CRISPR knockout of candidate regulators (e.g., NLRP3, ASC, ZBP1, TAK1, ATG5) in macrophage cell lines or primary cells can determine their necessity for NLRP3 inflammasome assembly. Knockout of positive regulators abolishes speck formation and IL-1beta secretion, while knockout of negative regulators enhances these responses [1,2,3,5].
Point Mutation
Point mutations in NLRP3 (e.g., disease-associated gain-of-function mutations) can be introduced using CRISPR base editing or homology-directed repair to study their impact on inflammasome assembly. This approach helps dissect the contribution of specific residues to oligomerization and activation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) at the endogenous NLRP3 or ASC locus allows real-time visualization of inflammasome assembly in live cells. Knock-in of epitope tags facilitates immunoprecipitation and proteomic analysis of the complex.
Overexpression
Overexpression of wild-type or mutant forms of NLRP3, ASC, or regulators via lentiviral transduction can enhance inflammasome assembly and identify gain-of-function phenotypes. This is useful for studying the effects of specific variants or for screening inhibitors [2,6].
How EDITGENE Supports regulation of NLRP3 inflammasome complex assembly Research
Researchers studying regulation of NLRP3 inflammasome complex assembly-related genes often need to determine whether a candidate gene is causally involved in this process or merely correlated with it. CRISPR-based models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of NLRP3 inflammasome complex assembly research.
Frequently Asked Questions About regulation of NLRP3 inflammasome complex assembly
What is GO:1900225?
GO:1900225 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of NLRP3 inflammasome complex assembly.
What genes are involved in regulation of NLRP3 inflammasome complex assembly?
Key genes include NLRP3, ASC (PYCARD), CASP1, ZBP1, TAK1 (MAP3K7), HK1/HK2, VDAC1/2/3, ATG5, ATG7, SQSTM1, OPTN, NFKB1, IL1B, IL18, GSDMD, P2RX7, and NEK7 [1,2,3,5,6].
How is NLRP3 inflammasome assembly regulated?
It is regulated by priming (NF-kB-mediated upregulation of NLRP3 and pro-IL-1beta), post-translational modifications, autophagy/mitophagy, ZBP1/TAK1 signaling, and metabolic factors such as hexokinase dissociation from mitochondria [1,2,3,5,6].
What diseases are associated with dysregulated NLRP3 inflammasome assembly?
Diseases include cryopyrin-associated periodic syndromes, Alzheimer's disease, Parkinson's disease, type 2 diabetes, atherosclerosis, inflammatory bowel disease, and cancer [1,7].
What is the role of autophagy in NLRP3 inflammasome regulation?
Autophagy and mitophagy negatively regulate NLRP3 inflammasome assembly by degrading inflammasome components or damaged mitochondria, thereby limiting inflammation.
How do ZBP1 and TAK1 regulate NLRP3 inflammasome assembly?
ZBP1 senses nucleic acids and promotes inflammasome activation, while TAK1 restricts assembly to prevent excessive inflammation; together they control PANoptosis [3,5].
What experimental models are used to study NLRP3 inflammasome assembly?
Common models include CRISPR knockout and knock-in cell lines, primary macrophages, and mouse models with specific mutations in NLRP3 or regulators [1,2].
What methods are used to measure NLRP3 inflammasome assembly?
Methods include ASC speck imaging, IL-1beta ELISA, caspase-1 Western blot, immunoprecipitation-mass spectrometry, and CRISPR screens [1,4].
Can CRISPR be used to study NLRP3 inflammasome assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the causal roles of genes in NLRP3 inflammasome assembly [1,2].
What services does EDITGENE offer for NLRP3 inflammasome research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for studying regulation of NLRP3 inflammasome complex assembly.
Conclusion
Regulation of NLRP3 inflammasome complex assembly (GO:1900225) is a critical biological process that controls innate immune responses and inflammation. Dysregulation of this process contributes to a wide range of human diseases, making it an attractive therapeutic target. Advances in CRISPR-based models and screening technologies have accelerated the discovery of novel regulators and mechanisms. EDITGENE offers comprehensive services to support research on this pathway, from gene editing to bioinformatics analysis.
References
- 1. Xu J et al.. 2023. The NLRP3 inflammasome: activation and regulation.. Trends Biochem Sci 48(4):331-344 PMID: 36336552
- 2. Gupta S et al.. 2025. Regulation of the NLRP3 inflammasome by autophagy and mitophagy.. Immunol Rev 329(1):e13410 PMID: 39417249
- 3. Zheng M et al.. 2020. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis).. Immunol Rev 297(1):26-38 PMID: 32729116
- 4. Jo EK et al.. 2016. Molecular mechanisms regulating NLRP3 inflammasome activation.. Cell Mol Immunol 13(2):148-59 PMID: 26549800
- 5. Malireddi RKS et al.. 2019. ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis).. Front Cell Infect Microbiol 9:406 PMID: 31850239
- 6. Baik SH et al.. 2023. Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation.. Sci Immunol 8(84):eade7652 PMID: 37327321
- 7. Paik S et al.. 2021. An update on the regulatory mechanisms of NLRP3 inflammasome activation.. Cell Mol Immunol 18(5):1141-1160 PMID: 33850310
- 8. Zhang JR et al.. 2024. Augmented microglial endoplasmic reticulum-mitochondria contacts mediate depression-like behavior in mice induced by chronic social defeat stress.. Nat Commun 15(1):5199 PMID: 38890305
